Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters
Noriaki Nakai, Gunther Hartmann, Saburo Kishimoto, et al.
Pigment Cell & Melanoma Research (2010) Vol. 23, Iss. 5, pp. 607-619
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Antitumour dendritic cell vaccination in a priming and boosting approach
Alexandre Harari, Michele Graciotti, Michal Bassani‐Sternberg, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 9, pp. 635-652
Closed Access | Times Cited: 225
Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
Alfonso Serrano del Valle, Alberto Anel, Javier Naval, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 177
Necroptotic cell death in anti‐cancer therapy
Olga Krysko, Tania Løve Aaes, Valerian E. Kagan, et al.
Immunological Reviews (2017) Vol. 280, Iss. 1, pp. 207-219
Closed Access | Times Cited: 148
Dendritic cells in triple-negative breast cancer: From pathophysiology to therapeutic applications
Ana Isabel Sebastião, Gabriel Chahade Sibanto Simões, Filomena Oliveira, et al.
Cancer Treatment Reviews (2025) Vol. 133, pp. 102884-102884
Open Access | Times Cited: 1
CD8+tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma
Hiroko Fujii, Akiko Arakawa, Daisuke Utsumi, et al.
International Journal of Cancer (2013) Vol. 134, Iss. 10, pp. 2393-2402
Open Access | Times Cited: 84
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
Lien Vandenberk, Jochen Belmans, Matthias Van Woensel, et al.
Frontiers in Immunology (2016) Vol. 6
Open Access | Times Cited: 84
Interferon: Current Status and Future Prospects in Cancer Therapy
Ben X. Wang, Ramtin Rahbar, Eleanor N. Fish
Journal of Interferon & Cytokine Research (2011) Vol. 31, Iss. 7, pp. 545-552
Closed Access | Times Cited: 82
Twelve-year survival and immune correlates in dendritic cell–vaccinated melanoma patients
Stefanie Groß, Michael Erdmann, Ina Haendle, et al.
JCI Insight (2017) Vol. 2, Iss. 8
Open Access | Times Cited: 79
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients
Laura Ridolfi, M. Petrini, Anna Maria Granato, et al.
Journal of Translational Medicine (2013) Vol. 11, Iss. 1, pp. 135-135
Open Access | Times Cited: 65
Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation
Barbara Behm, Pietro Di Fazio, Patrick Michl, et al.
Gut (2014) Vol. 65, Iss. 1, pp. 134-143
Open Access | Times Cited: 56
Cancer Vaccines in Ovarian Cancer: How Can We Improve?
Silvia Martin Lluesma, Anita Wolfer, Alexandre Harari, et al.
Biomedicines (2016) Vol. 4, Iss. 2, pp. 10-10
Open Access | Times Cited: 55
Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
Lien Vandenberk, Abhishek D. Garg, Tina Verschuere, et al.
OncoImmunology (2015) Vol. 5, Iss. 2, pp. e1083669-e1083669
Open Access | Times Cited: 54
Exosomes derived from rAAV/AFP-transfected dendritic cells elicit specific T cell-mediated immune responses against hepatocellular carcinoma
Jieyu Li, Shenglan Huang, Zhifeng Zhou, et al.
Cancer Management and Research (2018) Vol. Volume 10, pp. 4945-4957
Open Access | Times Cited: 51
Plasma-Activated Medium Potentiates the Immunogenicity of Tumor Cell Lysates for Dendritic Cell-Based Cancer Vaccines
Sergej Tomić, Anđelija Petrović, Nevena Puаč, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1626-1626
Open Access | Times Cited: 35
IL-15 and Type I Interferon Are Required for Activation of Tumoricidal NK Cells by Virus-Infected Dendritic Cells
Jeanette E. Boudreau, Kyle B. Stephenson, Fuan Wang, et al.
Cancer Research (2011) Vol. 71, Iss. 7, pp. 2497-2506
Open Access | Times Cited: 55
Microenvironment and tumor progression of melanoma: New therapeutic prospectives
Gerardo Botti, Margherita Cerrone, Giosuè Scognamiglio, et al.
Journal of Immunotoxicology (2012) Vol. 10, Iss. 3, pp. 235-252
Closed Access | Times Cited: 47
Dendritic cell-based vaccine in advanced melanoma
Laura Ridolfi, M. Petrini, Laura Fiammenghi, et al.
Melanoma Research (2011) Vol. 21, Iss. 6, pp. 524-529
Closed Access | Times Cited: 36
Therapeutic Dendritic Cell-Based Cancer Vaccines: The State of the Art
Marius Strioga, Thomas Felzmann, Daniel J. Powell, et al.
Critical Reviews in Immunology (2013) Vol. 33, Iss. 6, pp. 489-547
Closed Access | Times Cited: 35
Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: To use or not to use?
Marius Strioga, Adas Darinskas, Vita Pašukonienė, et al.
Vaccine (2014) Vol. 32, Iss. 32, pp. 4015-4024
Closed Access | Times Cited: 33
Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation
Brendon J. Coventry, Ashdown
Cancer Management and Research (2012), pp. 137-137
Open Access | Times Cited: 33
Rationale for the Combination of Dendritic Cell-Based Vaccination Approaches With Chemotherapy Agents
Iva Truxová, Michal Hensler, Petr Škapa, et al.
International review of cell and molecular biology (2016), pp. 115-156
Closed Access | Times Cited: 27
IL-18 Regulates Melanoma VLA-4 Integrin Activation through a Hierarchized Sequence of Inflammatory Factors
María Valcárcel, Teresa Carrascal, Olatz Crende, et al.
Journal of Investigative Dermatology (2013) Vol. 134, Iss. 2, pp. 470-480
Open Access | Times Cited: 26
Fast Dendritic Cells Stimulated with Alternative Maturation Mixtures Induce Polyfunctional and Long-Lasting Activation of Innate and Adaptive Effector Cells with Tumor-Killing Capabilities
Chiara Massa, Barbara Seliger
The Journal of Immunology (2013) Vol. 190, Iss. 7, pp. 3328-3337
Open Access | Times Cited: 21
Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience
Francesco De Rosa, Laura Ridolfi, Laura Fiammenghi, et al.
Melanoma Research (2017) Vol. 27, Iss. 4, pp. 351-357
Closed Access | Times Cited: 19
Natural Killer T Cells in Advanced Melanoma Patients Treated with Tremelimumab
F. Javier Ibarrondo, Otto O. Yang, Thinle Chodon, et al.
PLoS ONE (2013) Vol. 8, Iss. 10, pp. e76829-e76829
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top